Home › SEC Filings › Press Releases
Press Releases
All Current Report (8-K)Annual Report (10-K)Quarterly Report (10-Q)Form 4 Insider TradesSC 13D Beneficial Ownership13F Institutional HoldingsPress ReleasesInsider Cluster ActivityInsider Buy Activity
Theme?
All themes Artificial IntelligenceSemiconductorsQuantum ComputingSpace & SatellitesRobotics & AutomationElectric VehiclesClean & Renewable EnergyBattery & Energy StorageNuclear & FusionCybersecurityCloud & SaaSFintech & PaymentsCrypto & BlockchainGenomics & Gene EditingBiotech & Drug DiscoveryE-commerce & PlatformsStreaming & Digital MediaGaming & EsportsDefense TechCannabis
| Ticker | Type | Sentiment | Impact | Summary | Date |
|---|---|---|---|---|---|
| ADT | PRESS-RELEASE | neutral | 1/10 | ADT Inc. announced it will report its Q2 2026 results on July 30. | Jul 16, 2026 |
| COSM | PRESS-RELEASE | neutral | 3/10 | Cosmos Health announced the repurchase of an additional 250,000 shares at ~$0.2782 each, bringing total buybacks under i | Jul 16, 2026 |
| NBN | PRESS-RELEASE | neutral | 1/10 | Northeast Bank announced it will report its fiscal Q4 2026 results on July 27, 2026. | Jul 16, 2026 |
| SGU | PRESS-RELEASE | neutral | 2/10 | Star Group, L.P. declared its regular quarterly distribution of $0.1975 per common unit for the quarter ended June 30, 2 | Jul 16, 2026 |
| WABC | PRESS-RELEASE | neutral | 4/10 | Westamerica Bancorporation reported Q2 2026 diluted EPS of $1.17, beating the $1.09 consensus by 7.3%, but net income fe | Jul 16, 2026 |
| SCI | PRESS-RELEASE | neutral | 1/10 | Service Corporation International announced it will report its Q2 2026 results on July 29, 2026. | Jul 16, 2026 |
| APM | PRESS-RELEASE | neutral | 5/10 | Aptorum Group announced that its merger with DiamiR Biosciences is expected to close on or about July 20, 2026, with the | Jul 16, 2026 |
| CNP | PRESS-RELEASE | neutral | 2/10 | CenterPoint Energy declared a regular quarterly common stock dividend of $0.2400 per share, a $0.01 increase over the pr | Jul 16, 2026 |
| LMT | PRESS-RELEASE | bullish | 6/10 | Lockheed Martin was awarded a $10.5 billion, 12-year contract from U.S. Special Operations Command (USSOCOM) for the Spe | Jul 16, 2026 |
| SRXH | PRESS-RELEASE | bullish | 6/10 | SRX Global (SRXH) received written notification from NYSE Regulation confirming it is back in compliance with continued | Jul 16, 2026 |
| KDK | PRESS-RELEASE | neutral | 2/10 | Kodiak AI announced it will report Q2 2026 earnings on August 6, 2026, after market close. This is a routine earnings da | Jul 16, 2026 |
| DAIO | PRESS-RELEASE | neutral | 1/10 | Data I/O Corporation announced it will report its Q2 2026 results on July 30, 2026. | Jul 16, 2026 |
| ARTL | PRESS-RELEASE | neutral | 4/10 | Artelo Biosciences announced new preclinical data for ART26.12, its FABP5 inhibitor, showing efficacy comparable to napr | Jul 16, 2026 |
| BELFA | PRESS-RELEASE | neutral | 1/10 | Bel Fuse Inc. announced it will host a conference call on July 29, 2026 to discuss its Q2 2026 results. | Jul 16, 2026 |
| VCEL | PRESS-RELEASE | neutral | 1/10 | Vericel Corporation announced it will report its Q2 2026 results on July 30, 2026. | Jul 16, 2026 |
| BRCB | PRESS-RELEASE | neutral | 2/10 | Black Rock Coffee Bar announced the opening of a new location in Glendale, AZ, expanding its Phoenix-area presence to 58 | Jul 16, 2026 |
| CGNX | PRESS-RELEASE | neutral | 1/10 | Cognex Corporation announced it will report its Q2 2026 results on August 5, 2026. | Jul 16, 2026 |
| AME | PRESS-RELEASE | neutral | 1/10 | AMETEK, Inc. announced it will host a conference call on August 4, 2026 to discuss its Q2 2026 results. | Jul 16, 2026 |
| PTCT | PRESS-RELEASE | neutral | 1/10 | PTC Therapeutics, Inc. announced it will report its Q2 2026 results on July 30, 2026. | Jul 16, 2026 |
| INSG | PRESS-RELEASE | neutral | 1/10 | Inseego Corp. announced it will report its Q2 2026 results on August 5, 2026. | Jul 16, 2026 |
| FRMM | PRESS-RELEASE | bullish | 5/10 | Forum Markets acquired a CFM56-7B aircraft engine for ~$12M in cash, expanding its aviation portfolio to four income-gen | Jul 16, 2026 |
| BSVN | PRESS-RELEASE | bearish | 6/10 | Bank7 Corp. reported Q2 2026 earnings with net income of $8.35M ($0.87 diluted EPS), a 24.8% decline YoY from $11.11M ($ | Jul 16, 2026 |
| PLD | PRESS-RELEASE | bullish | 7/10 | Prologis reported Q2 2026 Core FFO of $1.63/share, beating the Street consensus of $1.53 by 6.5%, and raised full-year 2 | Jul 16, 2026 |
| IQST | PRESS-RELEASE | bullish | 6/10 | iQSTEL reported preliminary H1 2026 revenue of $207M, up 59% YoY from $130M, and expects to surpass a $500M annual reven | Jul 16, 2026 |
| CJMB | PRESS-RELEASE | neutral | 4/10 | Callan JMB announced a strategic partnership with Alabama State University to support a pharmaceutical manufacturing eco | Jul 16, 2026 |
| GRFS | PRESS-RELEASE | neutral | 4/10 | Grifols announced first patient dosing in two Phase 3 trials (SIGMA and XPERT) seeking U.S. label expansion for its immu | Jul 16, 2026 |
| QUCY | PRESS-RELEASE | neutral | 4/10 | Quantum Cyber announced $2.09M in purchase orders at its subsidiary Quantum Drones Corporation, received as part of the | Jul 16, 2026 |
| CRON | PRESS-RELEASE | neutral | 1/10 | Cronos Group Inc. announced it will host a conference call on August 6, 2026 to discuss its Q2 2026 results. | Jul 16, 2026 |
| BCTXL | PRESS-RELEASE | neutral | 3/10 | BriaCell announced that Sunnybrook's Odette Cancer Centre has joined its pivotal Phase 3 study of Bria-IMT plus an immun | Jul 16, 2026 |
| MDCX | PRESS-RELEASE | bullish | 5/10 | Medicus Pharma received FDA feedback and central IRB approval for its optimized Phase 2 study of Teverelix in men with a | Jul 16, 2026 |